Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Non-Small-Cell Lung/therapy; Lung Neoplasms/pathology; Neoplasm Recurrence, Local/therapy; Protein Kinase Inhibitors/pharmacology; Small Cell Lung Carcinoma/therapy; Acrylamides/pharmacology; Acrylamides/therapeutic use; Adult; Aniline Compounds/pharmacology; Aniline Compounds/therapeutic use; Biopsy; Carcinoma, Non-Small-Cell Lung/genetics; Carcinoma, Non-Small-Cell Lung/pathology; Cisplatin/therapeutic use; Drug Resistance, Neoplasm/drug effects; Epirubicin/therapeutic use; ErbB Receptors/antagonists & inhibitors; ErbB Receptors/genetics; Erlotinib Hydrochloride/therapeutic use; Fatal Outcome; Female; Humans; Lung/diagnostic imaging; Lung/pathology; Lung/surgery; Lung Neoplasms/diagnosis; Lung Neoplasms/genetics; Lung Neoplasms/therapy; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local/diagnosis; Neoplasm Recurrence, Local/genetics; Neoplasm Recurrence, Local/pathology; Pneumonectomy; Protein Kinase Inhibitors/therapeutic use; Small Cell Lung Carcinoma/diagnosis; Small Cell Lung Carcinoma/genetics; Small Cell Lung Carcinoma/pathology; Tomography, X-Ray Computed; Treatment Outcome